Clinical Trial Update: Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial [Phase 2]

View source ↗

Summary

Phase 2 BRIGHT trial combines immunotherapy with radiation therapy to potentially avoid bladder removal after shrinking muscle-invasive bladder cancer; recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer
• Stage Iiia Bladder Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | Phase 2 | Status: RECRUITING